Micro & Small Cap Conference
May 3rd and May 4 Live at The Westin New York Grand Central
Investor Summit is the largest truly independent Investor conference, solely focused on connecting companies with qualified investors who have intent to buy on the open market. We provide a seamless experience that drives ROI for presenting companies.
To attend, just sign up to participate and stay tuned for more updates!
B2I DIGITAL, Inc. is a sponsor of the 2022 Investor Summit Conference presented by Investor Summit Group. B2I DIGITAL, Inc. is not an affiliate of Investor Summit Group and is not authorized to represent or act on behalf of Investor Summit Group, in any capacity. Investor Summit Group has not reviewed and approved the content contained on the b2idigital.com website. No content contained herein shall be considered an offer to solicit the sale of any security.
WHY SHOULD YOU ATTEND?
First live Small & Microcap conference on the East Coast
High pent up demand from investors to meet live (expected 250+ quality investors)
Scheduled 1x1 meetings with qualified investors (average 8)
Includes live stream 30 minute presentation, professionally recorded and edited
Webinar promoted and hosted on website for 90 days and distributed in newsletter to 30k investors
Top rated customer service from start to finish
Presenting companies receive a personalized consultation with B2i Digital's CEO on how to leverage digital marketing pre and post event to maximize your exposure to the investor community. Plus B2i will leverage its 30K+ social media followers to amplify your investor awareness
Learn About Select Presenting Companies
Read a quick summary of each presenting company and click through to the IR section of their websites.
More companies will be added to B2i Digital daily. This is only a small sample of all the companies registered to present.
Pyrogenesis Canada, Inc.
$PYR, a high-tech company, is a leader in the design, development, manufacture and commercialization of advanced plasma processes and sustainable solutions which reduce greenhouse gases (GHG), and are economically attractive alternatives to conventional “dirty” processes.
Sachem Capital Corp.
Sachem Capital Corp. specializes in originating, underwriting, funding, servicing, and managing a portfolio of first mortgage loans. It offers short-term (i.e., three years or less) secured, nonbanking loans (sometimes referred to as “hard money” loans) to real estate investors to fund their acquisition, renovation, development, rehabilitation or improvement of properties located primarily in Connecticut, as well as Florida, Massachusetts and New York.
MetroOne Telecommunications, Inc.
Metro One Telecommunications Inc. is changing the way retailers integrate mobile commerce solutions within their businesses. The company’s unique ability to merge mobile tech, AI and Machine Learning enables retailers to quickly and easily put their businesses online and, significantly increase customer retention, basket size and lifetime value.
HUMBL is a Web3 company that has developed a full technology stack of blockchain solutions across a number of different verticals. The HUMBL consumer division include a mobile wallet, NFTs and ticketing, in which customers can buy crypto, earn interest, use and send USD stablecoins and up to 20+ digital assets. The HUMBL commercial division develops customized blockchain-as-a-service programs, such as mobile IDs and verifiable credentials, for government and private sector customers.
Stran & Company, Inc.
Stran is the chosen partner of many Fortune 500 companies, across a variety of industries, to execute their promotional marketing, loyalty and incentive, sponsorship activation, recruitment, retention, and wellness campaigns. Stran provides world-class customer service and utilizes cutting-edge technology, including efficient ordering and logistics technology to provide order processing, warehousing and fulfillment functions.
PolyPid Ltd. is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid’s proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months.
Hooker Furnishings Corp.
Headquartered in Martinsville, VA, Hooker Furnishings is ranked among the nation's largest publicly traded furniture sources and encompasses 12 operating businesses. Hooker Furnishings operates distribution centers in the United States, China, and Vietnam. The company's stock is listed on the Nasdaq Global Select Market under the symbol HOFT.
Li-Metal is a Canadian-based company developing lithium metal anodes and lithium metal production technologies for use in next-generation batteries. Our production methods are significantly more sustainable than existing products and offer lighter, more energy-dense and safer batteries that are critical to tomorrow’s electric vehicles.
Artelo Biosciences, Inc.
Artelo Biosciences, a clinical stage biopharmaceutical company developing a portfolio of therapeutic lipid-signaling modification product candidates focused on the treatment of cancer and other serious diseases, is expecting multiple data readouts in 2022 for its lead program's clinical study in cancer anorexia.
Neon Bloom, Inc.
Neon Bloom, Inc., doing business as Bazelet Health Systems, Inc. ("Bazelet"), holds the exclusive license to grow in the United States a patented zero-THC, high CBG Cannabis sativa L plant which received United States Patent No. PP32,725 on January 5, 2021. The patented plant, which was named PAN2020, is remarkably high in Cannabigerol (CBG) with undetectable levels (zero percent) of both Cannabidiol (CBD) and Tetrahydrocannabinol (THC).
Optimus Healthcare, Inc.
Optimus Healthcare Services is focused on creating a network of innovative healthcare companies that advance clinical research, disease management and improve physician/patient interactions. Optimus Healthcare accomplishes this by acquiring controlling interest in a variety of healthcare-related businesses and then enhances the attributes of its portfolio companies by improving the operational, technological and managerial capabilities of each company.
T Stamp, Inc.
Trust Stamp, the Privacy-First Identity Company, is a global provider of AI-powered identity services for use in multiple sectors including banking and finance, regulatory compliance, government, real estate, communications, and humanitarian services. Its technology empowers organizations with advanced biometric identity solutions that reduce fraud, protect personal data privacy, increase operational efficiency, and reach a broader base of users worldwide through its unique data transformation and comparison capabilities.
Panacea Life Sciences Holdings, Inc.
Panacea Life Sciences Holdings, Inc. is a fully integrated FDA, cGMP certified, seed-to-sale cannabinoid product focused company. We research, develop, manufacture and commercialize raw materials derived from industrial hemp and custom formulate, manufacture and distribute softgels (both bovine and vegan), gummies, tinctures, sublingual tablets, patches, K-Tape, topical pain relief and skin care products as our base business.
Global Crossing Airlines Group, Inc.
Global Crossing Airlines (NEO: JET) (NEO: JET.B) (OTCQB: JETMF) is a US 121 domestic flag and supplemental airline flying the Airbus A320 family aircraft. GlobalX flies as an ACMI and wet-lease charter airline serving the US, Caribbean and Latin American markets. For more information, please visit www.globalxair.com.
Tower One Wireless Corp.
(OTCQB: TOWTF, CSE: TO)
Tower One Wireless Corp is a public company founded in 2015 with the mission to build, own, develop, and operate high quality build-to-suit multitenant communications infrastructure across South American markets in Colombia, Mexico, and Ecuador facilitating mobile communication coverage for nearly 198 million people across Latin America.
Exagen Inc. is a Patient Focused, Discovery Driven company with a growing menu of proprietary tests focusing in the area of Rheumatology and Autoimmune diseases. Our AVISE testing portfolio is specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management.